NCT02460341View on ClinicalTrials.gov

The Effects of Ondansetron on Brain Function

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

February 3, 2017

Study Completion Date

February 3, 2017

Conditions
Brain FunctionHealthy Adults
Interventions
DRUG

ondansetron

Ondansetron 8mg, 16mg, 24mg

DRUG

placebo

placebo pill

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02460341 - The Effects of Ondansetron on Brain Function | Biotech Hunter | Biotech Hunter